Consolidated Statements Of Operations (USD $)	3 Months Ended
	Sep. 30, 2011	Sep. 30, 2010
Consolidated Statements Of Operations [Abstract]
Revenue
Operating expenses:
General and administrative (including stock-based compensation (Note 8))	3,762,427	791,474
Research and development (including stock-based compensation (Note 8))	70,134	49,001
Total operating expenses	3,832,561	840,475
Loss from operations	(3,832,561)	(840,475)
Other expense (income):
Interest expense	7,215	4,125
Interest income	(1,007)	(2,233)
Total Nonoperating Income/Expense	6,208	1,892
Net loss	(3,838,769)	(842,367)
Net loss attributable to the noncontrolling interest	13,103	1,770
Net loss attributable to Bion	(3,825,666)	(840,597)
Conversion inducement (Note 8)	(548,580)
Dividends on preferred stock	(149,550)	(118,137)
Net loss applicable to Bion's common stockholders	$ (4,523,796)	$ (958,734)
Net loss applicable to Bion's common stockholders per basic and diluted common share	$ (0.34)	$ (0.08)
Weighted-average number of common shares outstanding:
Basic and diluted	13,450,823	12,080,554